TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression
Open Access
- 15 February 2018
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (3) , 1-13
Abstract
Early studies indicated that testicular nuclear receptor 4 (TR4) could function as a suppressor in the transcriptional regulation of the HBV core gene expression, which might then influence the development of hepatocellular carcinoma (HCC). The direct linkage between TR4 and HCC progression, however, remained unclear. Here, via a human clinical sample survey, we found that 13 of the 18 HCC patients studied had lower TR4 expression in metastatic lesions than in matched primary HCC lesions, suggesting that TR4 may play a negative role in HCC metastasis. Results from in vitro cell migration/invasion studied confirmed that TR4 could suppress HCC cell migration/invasion. Mechanism dissection revealed that TR4 might function through downregulating ephrin type-A receptor 2 (EphA2) expression at the transcriptional level via direct binding to the TR4REs located on the 5′ promoter of EphA2 to suppress HCC cell migration/invasion. Targeting the EphA2 via EphA2-siRNA partially reversed the enhanced HCC cell migration/invasion with confirmed TR4 knockdown. Notably, results from preclinical studies using in vivo mouse model with orthotopic xenograft of HCC LM3 cells also confirmed the in vitro findings. Taking these findings together, preclinical studies using multiple in vitro HCC cell lines and an in vivo mouse model all led to the conclusion that TR4 may function as a suppressor of HCC metastasis and that targeting this newly identified TR4-EphA2 signaling may improve our ability to suppress HCC metastasis.Keywords
This publication has 38 references indexed in Scilit:
- Testicular Nuclear Receptor 4 (TR4) Regulates UV Light-induced Responses via Cockayne Syndrome B Protein-mediated Transcription-coupled DNA RepairJournal of Biological Chemistry, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Emerging strategies for EphA2 receptor targeting for cancer therapeuticsExpert Opinion on Therapeutic Targets, 2010
- Overexpression of EphA2, MMP‐9, and MVD‐CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosisHepatology Research, 2009
- EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinomaInternational Journal of Cancer, 2009
- Hepatitis B and hepatocellular carcinoma #Hepatology, 2009
- Oxidative Stress Stimulates Testicular Orphan Receptor 4 through Forkhead Transcription Factor Forkhead Box O3aEndocrinology, 2008
- Subfertility with Defective Folliculogenesis in Female Mice Lacking Testicular Orphan Nuclear Receptor 4Molecular Endocrinology, 2008
- Deficits in Motor Coordination with Aberrant Cerebellar Development in Mice Lacking Testicular Orphan Nuclear Receptor 4Molecular and Cellular Biology, 2005
- Targeted Inactivation of Testicular Nuclear Orphan Receptor 4 Delays and Disrupts Late Meiotic Prophase and Subsequent Meiotic Divisions of SpermatogenesisMolecular and Cellular Biology, 2004